8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): April 19, 2022

Merit Medical Systems, Inc.

(Exact name of registrant as specified in its charter)

Utah	0-18592	87-0447695
(State or other jurisdiction of	(Commission	(I.R.S. Employer
incorporation or organization)	File Number)	Identification No.)

1600 West Merit Parkway
South Jordan, Utah	84095
(Address of principal executive offices)	(Zip Code)

(801) 253-1600

(Registrant's telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, no par value	MMSI	Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company        ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Chief Operating Officer Retirement

On April 21, 2022, Merit Medical Systems, Inc. (the “Company”) announced that Ron Frost has retired from his position as the Company’s Chief Operating Officer, effective April 19, 2022.

Appointment of Executive Officer

On April 21, 2022, the Company announced that, effective April 19, 2022, Neil Peterson, age 56, was appointed as the Company’s Chief Operating Officer. Prior to this appointment, Mr. Peterson served as the Company’s Vice President, Operations for the past five years, and he has been with the Company in various positions for the past 27 years. 

Mr. Peterson is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K, and does not have any family relationship with any other executive officer or board member required to be disclosed pursuant to Item 404(d) of Regulation S-K.

Item 8.01.  Other Events.

On April 21, 2022, the Company issued a press release announcing the retirement of Ron Frost as the Company’s Chief Operating Officer and the appointment of Neil Peterson as the Company’s Chief Operating Officer.

The Company’s press release announcing the retirement and appointment is included as Exhibit 99.1 of this report.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits

Exhibit No.	Exhibit
99.1	Press Release, dated April 21, 2022, entitled “Merit Medical Announces Chief Operating Officer Transition”
104	The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MERIT MEDICAL SYSTEMS, INC.
Date: April 22, 2022	By:	/s/ Brian G. Lloyd
		Brian G. Lloyd
		Chief Legal Officer and Corporate Secretary

3

EX-99.1

Exhibit 99.1

Merit Medical Announces Chief Operating Officer Transition  

Ronald A. Frost to Retire After More than 30 Years of Service

Neil Peterson, a 27-Year Company Veteran, Appointed COO

SOUTH JORDAN, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that Chief Operating Officer (COO) Ronald A. Frost has decided to retire for personal reasons. Neil Peterson, Vice President, Operations, has been appointed as COO, effective immediately. During his 27 years at Merit, Mr. Peterson has held multiple positions of increasing responsibility within the company, including the past five years as Vice President, Operations. In that position, Mr. Peterson was responsible for oversight of all operations at Merit’s headquarters facilities in South Jordan, Utah.

"For more than 30 years, Ron has been an integral part of the growth and development of our company,” said Fred P. Lampropoulos, Merit’s President and Chief Executive Officer. "We thank Ron for his many contributions during his three plus decades of service to the company and wish him the best in his retirement." “Ron will assist in the transfer of responsibilities to Neil as needed.”

"Given his lengthy service to Merit, including responsibilities in the company’s engineering and operations groups, Neil is well qualified to assume responsibility for our global operations," continued Lampropoulos. "We are proud to have a deep bench of talent and thank Neil for stepping into the COO role." 

ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,300 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore. 

 

TRADEMARKS Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc. and its subsidiaries in the United States and other jurisdictions. 

 

1

CONTACTS  

PR/Media Inquiries  Sarah Comstock 

Merit Medical  +1-801-432-2864 | sarah.comstock@merit.com 

  

INVESTOR INQUIRIES  Mike Piccinino, CFA, IRC  Westwicke - ICR  +1-443-213-0509 | mike.piccinino@westwicke.com  

2

XML

Document and Entity Information	Apr. 19, 2022
Document and Entity Information [Abstract]
Document Type	8-K
Document Period End Date	Apr. 19, 2022
Entity File Number	0-18592
Entity Registrant Name	MERIT MEDICAL SYSTEMS INC
Entity Incorporation, State or Country Code	UT
Entity Tax Identification Number	87-0447695
Entity Address, Address Line One	1600 West Merit Parkway
Entity Address, City or Town	South Jordan
Entity Address, State or Province	UT
Entity Address, Postal Zip Code	84095
City Area Code	801
Local Phone Number	253-1600
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	MMSI
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	false
Entity Central Index Key	0000856982
Amendment Flag	false